Development of Countermeasures Against Adverse Metabolic Effects of Shift Work

March 18, 2020 updated by: Frank AJL Scheer, PhD, Brigham and Women's Hospital
The goal of this application is to determine whether changing the timing of food intake prevents the adverse metabolic effects of circadian misalignment.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Shift work is associated with circadian misalignment and an increased risk for the development diabetes, obesity, and cardiovascular disease. This research will determine whether changing the feeding schedule can prevent metabolic alterations that can lead to the abovementioned disorders. This research will provide mechanistic insight and may provide a novel therapeutic approach against the increased risk for diabetes, obesity, and cardiovascular disease among shift workers.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Brigham and Women's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 18.5 and 29.9 kgm-2
  • Healthy adults with regular sleep-wake timing
  • Non-smokers
  • Completion of medical and psychological screening tests
  • Able to spend 14 consecutive days in the sleep laboratory

Exclusion Criteria:

  • BMI <18.5 or > 29.9 kgm-2
  • History of neurological or psychiatric disorder
  • History of sleep disorder or regular use of sleep-promoting medication
  • Current prescription, herbal, or over-the-counter medication use
  • Traveling across 2 or more time zones within past 3 months
  • Donating blood within past 8 weeks
  • Worked night or rotating shift work within past 3 years
  • Hearing impairment
  • Drug or alcohol dependency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
During Forced Desynchrony sleep and wake will occur at different circadian phases, while meals are restricted to the biological day.
Other: Control
During Forced Desynchrony sleep and wake, as well as meals, will occur at different circadian phases.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in plasma leptin levels across sleep/wake cycle
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Frequent blood samples
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Change in circadian profile of plasma leptin
Time Frame: During constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
Frequent blood samples
During constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
Change in glucose tolerance
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Frequent blood samples before and after standardized meals
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Change in circadian profile of plasma glucose levels
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Frequent blood samples
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Change in plasma insulin levels after standardized test meal
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Frequent blood samples before and after standardized meals
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Change in circadian profile of plasma insulin levels
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
Frequent blood samples
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
o Change in circadian phase markers, such as from core body temperature, melatonin, and cortisol
Time Frame: Core temperature and frequent blood samples
Core temperature sensor throughout protocol, days 1-14. Frequent blood samples during constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
Core temperature and frequent blood samples
Changes circadian rhythm in resting energy expenditure
Time Frame: During constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
Indirect calorimetry
During constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
Change in hunger and appetite, mood, and cognitive performance
Time Frame: Tests taken throughout the protocol, days 1-14
Subjective hunger ratings and cognitive tests performed via computer interface
Tests taken throughout the protocol, days 1-14
Changes in microbiota, gene expression, epigenetic or proteomic markers
Time Frame: samples taken during forced desychrony (days 7-11) and the constant routine protocols (days 3-4 and 11-13)
Frequent blood samples and saliva samples
samples taken during forced desychrony (days 7-11) and the constant routine protocols (days 3-4 and 11-13)
Changes in sleep
Time Frame: sleep periods following day 1, days 6-7 and days 10-11
Polysomnography
sleep periods following day 1, days 6-7 and days 10-11

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frank A Scheer, PhD, Brigham and Women's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 19, 2015

Primary Completion (Actual)

August 29, 2018

Study Completion (Actual)

August 29, 2018

Study Registration Dates

First Submitted

November 12, 2014

First Submitted That Met QC Criteria

November 12, 2014

First Posted (Estimate)

November 17, 2014

Study Record Updates

Last Update Posted (Actual)

March 19, 2020

Last Update Submitted That Met QC Criteria

March 18, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R01HL118601 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Circadian Dysregulation

Clinical Trials on Meal schedule

Subscribe